Cargando…

Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis

BACKGROUND: Neoadjuvant chemotherapy (NACT) may help reduce the difficulty of surgery and eliminate tiny tumor metastatic foci. It has been reported that 69.4% to 95% of patients with cervical cancer respond to NACT. The aim of this study was to evaluate the value of microvessel features in the pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Weili, Liang, Cong, Liu, Ping, Qi, Yingying, Shen, Hong, Li, Mingwei, Chen, Chunlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799237/ https://www.ncbi.nlm.nih.gov/pubmed/35116248 http://dx.doi.org/10.21037/tcr-20-2741

Ejemplares similares

Prediction of Response to Preoperative Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Using Multicenter CT-Based Radiomic Analysis
por: Tian, Xin, et al.
Publicado: (2020)

Prognostic value of microvessel density in cervical cancer
por: Hu, Xiaoli, et al.
Publicado: (2018)

Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study
por: Sun, Caixia, et al.
Publicado: (2019)

Stratified treatment of localized cervical esophageal squamous cell carcinoma induced by neoadjuvant immunotherapy plus chemotherapy (SCENIC)
por: Li, Chunguang, et al.
Publicado: (2022)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
por: Feng, Xiaojie, et al.
Publicado: (2020)

Expression of BDNF, TrkB, VEGF and CD105 is associated with pelvic lymph node metastasis and prognosis in IB2-stage squamous cell carcinoma
por: Qi, Yingying, et al.
Publicado: (2019)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Dong, Yanbo, et al.
Publicado: (2020)

Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China
por: Yan, Wenxing, et al.
Publicado: (2019)

Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis
por: Li, Weili, et al.
Publicado: (2021)

Neoadjuvant chemotherapy for locally invasive cervical cancer in pregnancy: two case reports
por: Li, Ming-Zhu, et al.
Publicado: (2019)

Predictive Value of Pretreatment Peripheral Neutrophil-to-Lymphocyte Ratio for Response to Neoadjuvant Chemotherapy and Breast Cancer Prognosis
por: Li, Xiaomin, et al.
Publicado: (2021)

A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer
por: Tian, Xun, et al.
Publicado: (2021)

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
por: Qian, Yi, et al.
Publicado: (2018)

Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016)

The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study
por: Li, Xiong, et al.
Publicado: (2015)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Correlations Between Intratumoral Microvessel Density and Histopathological Type or Neoadjuvant Radiotherapy for Rectal Carcinoma
por: DUMITRESCU, T., et al.
Publicado: (2015)

Effect of annualized surgeon volume on major surgical complications for abdominal and laparoscopic radical hysterectomy for cervical cancer in China, 2004–2016: a retrospective cohort study
por: Liang, Cong, et al.
Publicado: (2023)

REDD1 overexpression in oral squamous cell carcinoma may predict poor prognosis and correlates with high microvessel density
por: Feng, Yuanyong, et al.
Publicado: (2020)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy
por: Lin, Yu, et al.
Publicado: (2023)

Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma
por: Liu, Yinan, et al.
Publicado: (2014)

Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy
por: Nanno, Shigenori, et al.
Publicado: (2022)

A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy
por: Ou, Zhengjie, et al.
Publicado: (2021)

The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy
por: Wu, Miao‐Fang, et al.
Publicado: (2019)

Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
por: Krüger, Kristi, et al.
Publicado: (2021)

Pretreatment Microvessel Density for Predicting of Tumor Responsiveness to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
por: Boonya-Ussadorn, Chinakrit, et al.
Publicado: (2023)

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
por: Wu, Yanan, et al.
Publicado: (2017)

Safety and Feasibility of Esophagectomy Following Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Gu, Yi-Min, et al.
Publicado: (2022)

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002)

Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma
por: Woo, Jong-Yun, et al.
Publicado: (2015)

Fibrinogen–Albumin Ratio Index Exhibits Predictive Value of Neoadjuvant Chemotherapy in Osteosarcoma
por: Li, Zhendong, et al.
Publicado: (2022)

Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement
por: Wang, Yue, et al.
Publicado: (2011)

Research on the prognosis of different types of microvessels in bladder transitional cell carcinoma
por: Wang, Hai-Bo, et al.
Publicado: (2021)

Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
por: Huang, Yibao, et al.
Publicado: (2022)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)

Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma
por: Shen, Dijian, et al.
Publicado: (2021)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_634ul62sc5tn963bv1mm095fvg